Med Klin
-
CARCINOMA OF THE GALLBLADDER: Only patients suffering from advanced disease have symptoms, that is pain, jaundice, weight loss. Mean 5-year survival rate tends to be lower than 5%. ⋯ After radiotherapy tumor regression is observed in 80% of the patients. Their mean survival time is 10 months.
-
The availability of hemopoetic growth factors and the retransfusion of autologous peripheral blood stem cells (PBSC) have enabled high-dose chemotherapy (HDT) options for the treatment of advanced solid tumours, during recent years. Though the transfusion of PBSC can manage the myelosuppression, dose-escalation ist still limited by non-haematological toxicity. ⋯ High-dose chemotherapy will be of increasing importance in the treatment strategies of primary solid tumors, in the near future.